Gelteq Limited Ordinary Shares
Gelteq Limited Ordinary Shares (GELS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
gels · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Gelteq Limited Ordinary Shares (GELS) measures how much investors pay for each dollar of the company's trailing earnings. GELS's current PE ratio of N/A is calculated by dividing its stock price of $0.48 by its TTM earnings per share of $0.00.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2020 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Gelteq Limited Ordinary SharesYou GELS | $4M | N/A | — | $0.00 |
 Aytu BioPharma, Inc. AYTU | $19M | N/A | — | -$2.16 |
 Bullfrog AI Holdings, Inc. Common Stock BFRG | $7M | N/A | — | -$0.63 |
 Biofrontera Inc. BFRI | $12M | N/A | — | -$1.04 |
 BioNexus Gene Lab Corp. BGLC | $4M | N/A | — | -$1.61 |
 Cocrystal Pharma, Inc. COCP | $10M | N/A | — | -$0.78 |
 Evogene Ltd. EVGN | $5M | N/A | — | -$1.08 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | — | $0.00 | — | |
2024-06-30 FY2024 | — | $0.00 | — | |
2023-06-30 FY2023 | — | $-0.37 | — | |
2022-06-30 FY2022 | — | $-0.36 | — | |
2021-06-30 FY2021 | — | $-0.07 | — | |
2020-06-30 FY2020 | — | $-0.16 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Gelteq Limited Ordinary Shares (GELS) measures how much investors pay for each dollar of the company's trailing earnings. GELS's current PE ratio of N/A is calculated by dividing its stock price of $0.48 by its TTM earnings per share of $0.00.
Frequently asked questions
GELS pe ratio · 6 questionsGELS's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.48 and TTM EPS of $0.00. Data sourced from Financial Modeling Prep via GELS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Gelteq Limited Ordinary Shares SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08